Ginkgo to Acquire Zymergen: Expansion of Automation, Data Science Tools and Beyond
Ginkgo Bioworks, the biotech firm with a platform for cell programming, recently entered into a definitive agreement to acquire a …
Biopharma Insights
Toronto’s Blossoming AI-driven Drug Discovery Scene
Canada has established itself as a rapidly growing global hub for artificial intelligence (AI) innovation and commercialization. This roots deep …
3D Printed Muscle Tissues for Drug Discovery With Mantarray™ Platform by Curi Bio
Curi Bio, a developer of human stem cell-based platforms for drug discovery, announced the commercial launch of the Mantarray™ platform …
Transformational EGFR Drug Discovery
Lung cancer accounted for 18% of deaths caused by cancer in 2020, making it the leading cause of cancer mortality …
Valo Therapeutics Aims to Improve Personalized Immunotherapy With a New Tech
Valo Therapeutics Oy (ValoTx), the developer of antigen-coated oncolytic viruses and vaccine vectors as therapeutic vaccines against cancer and infectious …
7 Tips for Growing a Successful ‘AI in Pharma’ Business: Key Growth Strategy Lessons
The ‘AI in Pharma’ start-up space has been rapidly exploding, with new companies being formed every month. The explosion has …
AI-powered Cryo-EM Attracts Big Bucks And Promises To Disrupt Structural Biology
Shuimu BioSciences, a biotech start-up working towards the implementation of cryo-EM into drug discovery, got an investment from the internet …
Applying AI and HPC to Drug Design: a Survey of R&D Work
The motivation for this report In 2018, while at Supercomputing in Dallas I had a couple key encounters that profoundly …
The Aging Research Is On The Rise
It took more than eight decades since the landmark experiments on calorie restrictions in 1930th to get to a point …
How Data-sharing Technologies Bolster AI Progress in Medical Research
While artificial intelligence (AI) already proved to be a groundbreaking thing in many industries (robotics, finance, surveillance, cyber security, self-driving …
Professor Sidney Altman
Because of the war I’ve missed the news about the death of Sidney Altman on April 5, 2022. Altman is …
Tissue Selective E3 Ligase-based Degraders
The efficacy and selectivity of protein degrader drugs depend on their affinity to the target protein but also on the type …